HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcus Katoh Selected Research

EP-2104R

9/2008MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients.
8/2007Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent.
8/2005Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent.
3/2005Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent.
9/2004In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcus Katoh Research Topics

Disease

5Thrombosis (Thrombus)
11/2007 - 04/2004
3Stroke (Strokes)
12/2021 - 09/2008
3Venous Thrombosis (Deep-Vein Thrombosis)
03/2009 - 04/2004
2Pain (Aches)
01/2022 - 11/2020
2Neoplasms (Cancer)
01/2022 - 07/2004
2Acute Kidney Injury (Acute Renal Failure)
01/2017 - 03/2010
2Shock
11/2007 - 04/2004
2Pulmonary Embolism
08/2007 - 08/2005
2Coronary Thrombosis
03/2005 - 09/2004
1Aortic Aneurysm (Aneurysm, Aortic)
11/2021
1Aneurysm (Aneurysms)
11/2021
1Arthralgia (Joint Pain)
11/2020
1Tendinopathy (Tendonitis)
11/2020
1Mesenteric Ischemia
01/2018
1Ischemia
01/2017
1Renal Insufficiency (Renal Failure)
06/2014
1Peripheral Arterial Disease
10/2012
1Thrombocytopenia (Thrombopenia)
10/2012
1Obesity
08/2012
1Hemorrhage
08/2012
1Pathologic Constriction (Stenosis)
09/2010
1Fever (Fevers)
03/2010
1Abdominal Pain (Pain, Abdominal)
03/2010
1Gallstones (Gallstone)
03/2010
1Abscess
03/2010
1Renal Artery Obstruction (Renal Artery Stenosis)
10/2007
1Infections
11/2006
1Pneumothorax
11/2006
1Acute Coronary Syndrome
09/2004

Drug/Important Bio-Agent (IBA)

7Contrast MediaIBA
12/2021 - 09/2004
5FibrinIBA
03/2009 - 09/2004
5EP-2104RIBA
09/2008 - 09/2004
2Pharmaceutical PreparationsIBA
03/2009 - 08/2007
2Tissue Plasminogen Activator (Alteplase)FDA Link
11/2007 - 04/2004
1Biomarkers (Surrogate Marker)IBA
01/2018
1Fibroblast Growth Factor-23IBA
01/2017
1Cystatin CIBA
01/2017
1CreatinineIBA
01/2017
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2014
1Heparin (Liquaemin)FDA LinkGeneric
10/2012
1Phenobarbital (Luminal)FDA Link
09/2010
1ThrombinFDA Link
11/2007
1Fibrinogen (Factor I)FDA Link
09/2004
1Gadolinium DTPA (Magnevist)FDA Link
09/2004
1GadoliniumIBA
09/2004
12,4-thiazolidinedione (thiazolidinedione)IBA
07/2004
1PPAR gammaIBA
07/2004
1Carcinoembryonic AntigenIBA
07/2004
1SiliconIBA
04/2004

Therapy/Procedure

4Catheters
01/2018 - 11/2006
3Therapeutics
01/2022 - 11/2020
2Punctures
01/2022 - 08/2012
2Stents
10/2012 - 09/2004
2Thrombectomy
11/2007 - 04/2004
1Drug Therapy (Chemotherapy)
01/2022
1Radiotherapy
01/2022
1Endovascular Aneurysm Repair
11/2021
1Vascular Closure Devices
08/2012
1Laparoscopic Cholecystectomy
03/2010